New Tests (5)
Immunohistochemistry (IHC)
Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma Alternative Name Claudin 18 IHC, CLDN 18, CLDN 18.2 Methodology Immunohistochemistry (IHC) Test Description The…
Nucleic acid extraction
Extract and Hold Service, Hematologic Disorders Alternative Name Extract & Hold Methodology Nucleic acid extraction Test Description DNA, RNA or TNA (total nucleic…
Molecular
NEO | AML Express™ Alternative Name AML Express Rapid AML Methodology Molecular Test Description The NEO | AML Express assay is a next-generation sequencing (NGS)…
Molecular
NRAS Mutation Analysis by PCR Alternative Name NRAS Gene Analysis Methodology Molecular Test Description The NRAS Mutation Analysis Assay is a real-time PCR-based…
Immunohistochemistry (IHC), In Situ Hybridization (ISH), Molecular, Morphologic Evaluation
Surgical Pathology Consultation Alternative Name Pathology consults, second opinions, morphology consults Methodology Immunohistochemistry (IHC) In Situ Hybridization (ISH) Molecular…
Immunohistochemistry (IHC)
BOB1 Methodology Immunohistochemistry (IHC) Test Description BOB1 is present in all B-cells expressing Ig. The combination of BOB1 and OCT2 staining is helpful in distinguishing between classical…
Molecular
Bone Marrow Failure NGS Panel Methodology Molecular Test Description Testing is performed by Fulgent Genetics. Patient and physician or genetic counselor signatures on the Fulgent Genetics Informed…
Molecular
BRAF Mutation Analysis by PCR Alternative Name BRAF V600 Methodology Molecular Test Description BRAF Mutation Analysis Assay is based on PCR amplification and…
FISH
BRAF Rearrangement Alternative Name BRAF translocation Methodology FISH Test Description Probes: BRAF (7q34) Disease(s): Brain cancer, thyroid cancer, melanoma…
Immunohistochemistry (IHC)
BRAF V600E Methodology Immunohistochemistry (IHC) Test Description A monoclonal antibody (IHC600) against mutant BRAF (V600E) permits fast assessment of the mutant protein expression throughout a…
Molecular
Brain NGS Fusion Panel Alternative Name Brain Tumor Fusion Panel Methodology Molecular Test Description The Brain Tumor NGS Fusion Panel is an RNA-based next-…
Immunohistochemistry (IHC)
BRCA1 Methodology Immunohistochemistry (IHC) Test Description BRCA1 (breast and ovarian cancer susceptibility protein 1) is a nuclear phosphoprotein that plays a role in maintaining genomic stability…
Molecular
BRCA1 and BRCA2 Focus Panel (Germline) Methodology Molecular Test Description Testing is performed by Fulgent Genetics. A complete test description, including list of genes tested, is available here…
Molecular
BRCA1 Single Gene (Germline) Methodology Molecular Test Description Testing is performed by Fulgent Genetics. Patient and physician or genetic counselor signatures on the Fulgent Genetics Informed…
Molecular
BRCA1/2 Mutation Analysis for Tumors Methodology Molecular Test Description BRCA1 and BRCA2 mutation analysis is performed by next-generation sequencing of all coding exons of the BRCA1 and BRCA2…
Molecular
BRCA2 Single Gene (Germline) Methodology Molecular Test Description Testing is performed by Fulgent Genetics. Patient and physician or genetic counselor signatures on the Fulgent Genetics …
Molecular
Breast Cancer Index® (BCI) Methodology Molecular Test Description Breast Cancer Index (BCI) is an RT-PCR assay performed on FFPE breast tumor tissue that integrates two gene expression-based…
Molecular
Breast NGS Fusion Panel Alternative Name Breast Fusion Panel Methodology Molecular Test Description The Breast NGS Fusion Panel is an RNA-based next-generation…
Immunohistochemistry (IHC)
Breast Triple Stain (CK5 + p63 + CK 8/18) Methodology Immunohistochemistry (IHC) Test Description The combination of CK5 + P63 + CK8/18 (Breast Triple Stain) can be useful in distinguishing ductal…
Immunohistochemistry (IHC)
BRG1 (SMARCA4) Methodology Immunohistochemistry (IHC) Test Description BRG1 (SMARCA4) is involved in chromatin remodeling, which regulates the binding of transcription factors to DNA.…
Molecular
BTK Inhibitor Acquired Resistance Panel Alternative Name BTK, BTK acquired resistance Methodology Molecular Test Description Concurrent bi-directional sequencing of…
Immunohistochemistry (IHC)
CA125 Methodology Immunohistochemistry (IHC) Test Description CA125 reacts with most epithelial ovarian neoplasms of serous, endometrioid, clear cell and undifferentiated types. CA125 is a useful…
Immunohistochemistry (IHC)
CA19.9 Methodology Immunohistochemistry (IHC) Test Description In normal tissues, the CA19.9 antigen has been demonstrated in ductal epithelium of the breast, kidney, salivary gland, sweat glands,…
Immunohistochemistry (IHC)
Calcitonin Methodology Immunohistochemistry (IHC) Test Description Calcitonin is secreted by thyroidal parafollicular cells of neuroectodermal origin, probably in response to hypercalcemia. The IHC…
Immunohistochemistry (IHC)
Calcium Stain Alternative Name Von Kossa Stain Methodology Immunohistochemistry (IHC) Test Description Special stain. Specimen Requirements…
Immunohistochemistry (IHC)
Caldesmon Methodology Immunohistochemistry (IHC) Test Description Caldesmon is a regulatory protein found in smooth muscle and tissues which interacts with actin, myosin, tryopomyosin and calmodulin.…
Immunohistochemistry (IHC)
Calponin Methodology Immunohistochemistry (IHC) Test Description Calponin, a calmodulin, is involved in the regulation of smooth muscle contraction. The expression of calponin is restricted to smooth…
Molecular
CALR Mutation Analysis Alternative Name CALR, calreticulin Methodology Molecular Test Description Fragment analysis of exon 9 of the CALR (calreticulin) gene for…
Immunohistochemistry (IHC)
Calretinin Methodology Immunohistochemistry (IHC) Test Description Calretinin is the most specific and reproducible positive marker of epithelial mesothelioma. Calretinin is a calcium-binding protein…
Immunohistochemistry (IHC)
CAM 5.2 Alternative Name Cytokeratin LMW Methodology Immunohistochemistry (IHC) Test Description Anti-Cytokeratin (CAM 5.2) has a primary reactivity with human keratin…